Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Location: United States
Total raised: $105M
Investors 3
| Date | Name | Website |
| - | Apollo Ven... | apollo.vc |
| - | Sofinnova ... | sofinnova.... |
| 17.12.2025 | SymBiosis | symbiosis.... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 27.12.2025 | Series B | $55M | Sofinnova ... |
| 29.03.2024 | - | $50M | - |
Mentions in press and media 7
| Date | Title | Description |
| 28.12.2025 | Aeovian Pharmaceuticals Secures $55M Series B for Groundbreaking Epilepsy Treatment | Aeovian Pharmaceuticals secured a significant $55 million Series B funding. This pivotal investment propels its lead candidate, AV078, into a Phase 2 study. AV078 is a first-in-class CNS-penetrant selective mTORC1 inhibitor. It targets seve... |
| 27.12.2025 | Aeovian Pharmaceuticals: $55 Million Series B Raised To Advance AV078 For Tuberous Sclerosis Complex-Related Refractory Epilepsy | Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company based in Berkeley, California, has closed an oversubscribed $55 million Series B financing to support completion of a Phase 2 proof-of-concept study for its lead candidate,... |
| 16.12.2025 | Woodchuck Receives Growth Investment | Woodchuck, a Grand Rapids, MI-based AI-powered climate-tech startup, received an investment from Michigan Rise, a venture investment subsidiary of the MSU Research Foundation. The amount of the deal was not disclosed. The company intends to... |
| 16.12.2025 | Aeovian Pharmaceuticals Raises $55M in Funding | Aeovian Pharmaceuticals, a Berkeley, CA-based clinical-stage biopharmaceutical company, raised $55M in funding. The round was led by Luma Group and CTI Life Sciences Fund, with participation from Foresite Capital, SymBiosis, the TSC Allianc... |
| 23.09.2024 | Longevity Startups Are Getting Funding, But Not As Fast As We’re Aging | 13 Shares Email Facebook Twitter LinkedIn We are all getting older. But never before have we been getting this much older. In the U.S., at least one in six people is now over the age of 65. At the same time, in most developed countries olde... |
| 29.03.2024 | Aeovian Pharmaceuticals Closes $50M Financing | Aeovian Pharmaceuticals, a Berkeley, CA-based clinical-stage biopharmaceutical company, raised $50M in funding. The round was led by Hevolution with participation from existing investors Apollo Health Ventures, Sofinnova Investments, venBio... |
| - | Aeovian Pharmaceuticals | “Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.” |